Mei-Shih Announces Board Approval to Cancel Fund Lending to Subsidiary Lotus International Pte. Ltd.
AI Summary (NQ-processed)
Mei-Shih Chemical Pharmaceutical Co., Ltd. has resolved at its board meeting to cancel a USD 20 million fund lending facility to its subsidiary, Lotus International Pte. Ltd., aligning with current operational realities.
AI Analysis
Frequently Asked Questions
Q: Who made the decision to cancel the fund lending?
A: The board of directors of Mei-Shih Chemical Pharmaceutical officially resolved the cancellation.
Q: Where is Lotus International Pte. Ltd. located?
A: It is a Singapore-incorporated entity serving as the international hub for the Mei-Shih Group.
Q: Will this affect future dividends?
A: Improved financial health may support stable dividend growth in the medium to long term.